Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

The Novel Insight of Gut Microbiota from Mouse Model to Clinical Patients and the Role of NF-κB Pathway in Polycystic Ovary Syndrome.

Author information

Affiliations

  • 1. Department of Pediatrics, Affiliated Hospital of Jiangnan University, Wuxi, 214122, Jiangsu, China.
      Authors
    • Kong FS 1, 2
    • Huang P 1, 2
    • Ma Y 1, 2
    (3 authors)
  • 2. Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
      Authors
    • Kong FS 1, 2
    • Huang P 1, 2
    • Chen JH 2
    • Ma Y 1, 2
    (4 authors)

ORCIDs linked to this article

Reproductive Sciences (Thousand Oaks, Calif.), 23 Apr 2024, 31(11):3323-3333
https://doi.org/10.1007/s43032-024-01562-3 PMID: 38653859 

Review

Abstract 

Polycystic Ovary Syndrome (PCOS) is a metabolic disorder characterized by hyperandrogenism and related symptoms in women of reproductive age. Emerging evidence suggests that chronic low-grade inflammation plays a significant role in the development of PCOS. The gut microbiota, a complex bacterial ecosystem, has been extensively studied for various diseases, including PCOS, while the underlying mechanisms are not fully understood. This review comprehensively summarizes the changes in gut microbiota and metabolites observed in PCOS and their potential association with the condition. Additionally, we discuss the role of abnormal nuclear factor κB signaling in the pathogenesis of PCOS. These findings offer valuable insights into the mechanisms of PCOS and may pave the way for the development of control and therapeutic strategies for this condition in clinical practice. By bridging the gap between mouse models and clinical patients, this review contributes to a better understanding of the interplay between gut microbiota and inflammation in PCOS, thus paving new ways for future investigations and interventions.

Full text links 

Read article at publisher's site: https://doi.org/10.1007/s43032-024-01562-3

References 

Articles referenced by this article (129)

Show 10 more references (10 of 129)

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

the Maternal and Child Health Research Project of Jiangsu in China (1)